Drug Database
Back to search

Italy· 045615010

MAVENCLAD*1 cpr 10 mg

A cladribine product containing cladribina, registered in Italy by MERCK EUROPE BV, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC L01BB04

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedMAVENCLAD*1 cpr 10 mgATCL01BB04REGISTER NO.045615010PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cladribinaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cladribine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01BB04 (cladribine), each read from that country’s own register.

  • This record: Italy
  • 9 of them publish a price we can compare per daily dose
Search cladribine products by name

Cladribine · ATC L01BB04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Cladribina
Manufacturer
MERCK EUROPE BV
Country
Italy (IT)
ATC code
L01BB04
ATC class
Cladribine
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    045615010
    MAVENCLAD*1 cpr 10 mg
    EUR 3166.64

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

409 interactions on record for cladribine.

Graded by severity as the source publishes them — 326 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cladribine against other medicinesHow interaction checks work

Cladribine · interactions on record

409 records

  • 326 severe
  • 79 moderate
  • 4 info

Most severe, free to view

  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • BetamethasoneA07EA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cladribine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cladribine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Leuject
  • Belgium · Leustatin
  • Bulgaria · Леуджект
  • Czechia · Leuject
  • Germany · Leustatin
  • Spain · Leustatin
  • Finland · Leuject
  • France · Leustatine
  • United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
  • Greece · Leustatin
  • Croatia · Leuject
  • Hungary · Leuject
  • Iceland · Mavenclad
  • Liechtenstein · Mavenclad
  • Luxembourg · Leustatin
  • Netherlands · Leustatin
  • Norway · Leuject, Mavenclad
  • Poland · Biodribin, Leuject
  • Portugal · Cladribina Generis, Leustatin
  • Romania · Leuject
  • Sweden · Leuject
  • Slovenia · Leuject

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4fbbf9c4-fb2a-4e4b-a2c3-308c73fb69bc
GET /v1/drugs/4fbbf9c4-fb2a-4e4b-a2c3-308c73fb69bc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 3166.64,
  "source": "aifa",
  "currency": "EUR",
  "strength": "CLADRIBINA 10MG 1 UNITA' USO ORALE",
  "substance": "Cladribina",
  "equivalence_group": "KRH",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about cladribine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console